Related Experiment Video
Updated: Jul 27, 2026
08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Life-threatening complications of systemic sclerosis
Moises Cossio1, Yamini Menon, Wendell Wilson
1Department of Medicine, Louisiana State University Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112, USA.
Critical Care Clinics
|November 7, 2002
Summary
Pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) requires specific diagnosis via right heart catheterization. Treatment varies, with some patients benefiting from calcium-channel blockers, while others need advanced therapies for improved outcomes.
Area of Science:
- Rheumatology
- Cardiology
- Pulmonology
Background:
- Pulmonary arterial hypertension (PAH) is a frequent complication in patients with systemic sclerosis (SSc).
- Accurate diagnosis and tailored treatment are crucial for managing SSc-associated PAH and its related complications.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for PAH in SSc patients.
- To differentiate SSc-related pulmonary and renal syndromes and their management.
Main Methods:
- Diagnostic approach involves Doppler echocardiography and right heart catheterization (RHC) for PAH confirmation and vasoreactivity assessment.
- Therapeutic strategies include calcium-channel blockers for vasoreactive patients and intravenous epoprostenol or oral endothelin-1 receptor antagonists for most SSc-PAH patients.
- Management of right ventricular failure focuses on vasodilators, inotropes, and diuretics, while carefully avoiding systemic hypotension.
Main Results:
- RHC is essential for confirming PAH and assessing vasoreactivity in SSc.
- Most SSc-PAH patients are not vasoreactive and benefit from specific PAH therapies.
- Scleroderma renal crisis, unlike scleroderma pulmonary renal syndrome, responds to ACE inhibition and renal replacement therapy.
Conclusions:
- Effective management of SSc-associated PAH involves precise diagnosis and targeted therapies.
- Distinguishing between scleroderma pulmonary renal syndrome and scleroderma renal crisis is vital for appropriate treatment and prognosis.
- Addressing gastrointestinal and cardiac complications is integral to comprehensive SSc care.
More Related Videos
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...